Innovative Medical (002173.SZ) released its half-year performance, with a net loss attributable to shareholders of 11.36 million yuan.

Wisdom Finance and Economics App news, Innovision Medical (002173.SZ) disclosed its 2025 interim report, reporting that the company achieved a revenue of 402 million yuan, a decrease of 1.6% year-on-year; the net profit attributable to the shareholders of the listed company was a loss of 11.36 million yuan, which narrowed year-on-year; the non-GAAP net profit was a loss of 12.88 million yuan, narrowing year-on-year; basic earnings per share was -0.03 yuan.